Greenwood Capital Associates’s iShares Biotechnology ETF IBB Stock Holding History

Greenwood Capital Associates’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,176	Closed	-$374K	–	220
2022 Q2	$374K	Buy	+3,176	New	+$377K	0.06%	183
2018 Q4	–	Sell	-34,494	Closed	-$4.21M	–	187
2018 Q3	$4.21M	Buy	+34,494	New	+$4.06M	0.92%	47
2017 Q4	–	Sell	-21,348	Closed	-$2.37M	–	226
2017 Q3	$2.37M	Buy	21,348 +18,342	+610%	+$1.96M	0.59%	77
2017 Q2	$311K	Buy	+3,006	New	+$296K	0.08%	140

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Greenwood Capital Associates's IBB Position: Q3 2022 in Review

Greenwood Capital Associates sold out of iShares Biotechnology ETF (IBB) in Q3 2022, closing a stake of 3,176 shares — an estimated $374K sold.

Greenwood Capital Associates first reported a position in IBB in Q2 2017 and held it in 4 quarters. The position peaked at $4.21M in Q3 2018. 829 funds tracked by Wall St. Rank hold IBB as of Q3 2022.

Greenwood Capital Associates reported no remaining iShares Biotechnology ETF position as of Q3 2022 after selling out during the quarter.
Greenwood Capital Associates sold 3,176 iShares Biotechnology ETF shares in Q3 2022, an estimated $374K.
Greenwood Capital Associates first reported a position in iShares Biotechnology ETF in Q2 2017 and held it in 4 quarters.
Greenwood Capital Associates's iShares Biotechnology ETF position peaked at $4.21M in Q3 2018.
829 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.

Based on Greenwood Capital Associates's 13F filing for Q3 2022, filed 10 Nov 2022.